Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPets at home Regulatory News (PETS)

Share Price Information for Pets at home (PETS)

Share Price is delayed by 15 minutes
Get Live Data
170.90    -3.10 (-1.78%)
Bid:
171.10
Ask:
171.40
Spread: 0.30 (0.175%)
Market Cap: £755.86m
PETS Live PriceLast checked at - London Stock Exchange

Intraday Pets at home Share Chart

FY26 pre-close statement

31 Mar 2026 07:00

RNS Number : 7165Y
Pets At Home Group Plc
31 March 2026
 

 

 

 

FOR IMMEDIATE RELEASE, 31 MARCH 2026

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION

 

Pets at Home Group Plc: FY26 pre-close statement

Pets at Home Group plc, the UK's leading pet care business, is pleased to provide a pre-close update in respect of the 52-week period to 26 March 2026.

Group underlying profit before tax (PBT) for FY26 is expected to be c£92m, in line with previous guidance.

Our 'Retail Turnaround Plan' is progressing and is on track across our 4 priority areas, Product, Price, Execution and Cost. We have implemented our price investments and completed our £20m Group overhead savings, and while the benefits of many initiatives still lie ahead of us, we are encouraged by the progress made. In H2, our Retail business has seen volume growth, and we delivered positive LFL sales growth, as guided, with Q4 improving sequentially over Q3. Retail will deliver underlying PBT of c£30m in FY26.

In line with our guidance, Vet Group will deliver PBT of c£83m, a further year of strong profit progress despite the expected slowdown in sales growth as our customer cohorts reach a typical lull in activity. Vet Group performance remains underpinned by growth in average transaction values alongside growth in Care Plan revenues and plans.

Non-underlying costs of c£7m have been incurred in the year, in line with previous guidance.

We expect to finish FY26 in a net debt position of c£20m, after having returned c£85m to shareholders via dividends and buybacks during the year.

Following extensive consultation with our investors, we are rebalancing the way we return cash to shareholders. We will not change the total amount we return to shareholders but we will rebase our dividend to a 50% payout ratio, with that cash 'saving' returned to shareholders via our buyback programme.

We welcome the Final Decision Report of the CMA's veterinary services market investigation. We continue to expect no adverse impact on the growth strategy or ambitions for our Vet Group from the outcome.

Looking ahead to FY27, at this stage, we have c80% of our energy and FX requirements hedged and are comfortable with current analyst consensus expectations for Group underlying PBT1.

Our next scheduled update will be our FY26 preliminary results announcement on 27 May 2026.

 

1. Current analyst consensus for FY27 Group underlying PBT is £99m with a range of £90m - £108m.

 

Investor Relations Enquiries

Pets at Home Group Plc:

Andrew Porteous, Director of Investor Relations +44 (0) 7740 361 849

Aaron Wood, Head of Investor Relations +44 (0) 7702 083 154

Media Enquiries

Pets at Home Group Plc:

Natalie Cullington, Head of Communications +44 (0) 7974 594 701

Citigate Dewe Rogerson:

Jos Bieneman +44 (0) 7834 336 650

About Pets at Home

Pets at Home Group Plc is the UK's leading pet care business, providing pets and their owners with the very best advice, products and care. Pet products are available online or from over 450 pet care centres, many of which also have vet practices and grooming salons. The Group also operates a leading small animal veterinary business, with over 450 veterinary general practices located both in our pet care centres and in standalone locations. For more information visit: http://petsathomeplc.com/

Disclaimer

This trading statement does not constitute an invitation to underwrite, subscribe for, or otherwise acquire or dispose of any Pets at Home Group Plc shares or other securities nor should it form the basis of or be relied on in connection with any contract or commitment whatsoever. It does not constitute a recommendation regarding any securities. Past performance, including the price at which the Company's securities have been bought or sold in the past, is no guide to future performance and persons needing advice should consult an independent financial adviser. Certain statements in this trading statement constitute forward-looking statements. Any statement in this document that is not a statement of historical fact including, without limitation, those regarding the Company's future plans and expectations, operations, financial performance, financial condition and business is a forward-looking statement. Such forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially. These risks and uncertainties include, among other factors, changing economic, financial, business or other market conditions. These and other factors could adversely affect the outcome and financial effects of the plans and events described in this statement. As a result, you are cautioned not to place reliance on such forward-looking statements. Nothing in this statement should be construed as a profit forecast.

This announcement contains information that is inside information for the purposes of Article 7 of the UK version of Regulation (EU) No. 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended (the Market Abuse Regulation ("MAR")). Upon the publication of this announcement, such information will no longer constitute inside information. Andrew Porteous, the Company's Director of Investor Relations, is the person responsible for making the notification for the purposes of Article 17 of MAR.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTJMMMTMTAJTPF
Date   Source Headline
30th Jun 20227:00 amRNSTransaction in Own Shares
29th Jun 20227:00 amRNSTransaction in Own Shares
28th Jun 20227:00 amRNSTransaction in Own Shares
27th Jun 20229:08 amRNSTransaction in Own Shares
24th Jun 20227:00 amRNSTransaction in Own Shares
23rd Jun 20222:04 pmRNSDirector/PDMR Shareholding
23rd Jun 20227:00 amRNSTransaction in Own Shares
22nd Jun 202211:52 amRNSTransaction in Own Shares
21st Jun 20229:02 amRNSTransaction in Own Shares
20th Jun 20227:00 amRNSCommencement of Share Buy-Back Programme
10th Jun 20227:00 amRNSAnnual Report & Accounts and Notice of AGM
8th Jun 20223:21 pmRNSDirector/PDMR Shareholding
8th Jun 202210:17 amRNSDirector/PDMR Shareholding
8th Jun 202210:15 amRNSDirector/PDMR Shareholding
8th Jun 202210:15 amRNSDirector/PDMR Shareholding
8th Jun 202210:13 amRNSDirector/PDMR Shareholding
7th Jun 20227:00 amRNSDividend Declaration
6th Jun 202211:18 amRNSDirector/PDMR Shareholding
1st Jun 20225:02 pmRNSDirector/PDMR Shareholding
1st Jun 20225:02 pmRNSDirector/PDMR Shareholding
1st Jun 20227:00 amRNSAppointment of CEO
27th May 20228:36 amRNSDirector/PDMR Shareholding
26th May 20227:04 amRNSDirector/PDMR Shareholding
25th May 202210:00 amRNSFinal Results
29th Mar 20223:15 pmRNSHolding(s) in Company
8th Mar 20229:39 amRNSHolding(s) in Company
7th Feb 20227:00 amRNSAppointment of CEO
27th Jan 20225:45 pmRNSHolding(s) in Company
26th Jan 20227:00 amRNSPets at Home Group Plc: Q3 FY22 Trading Statement
10th Dec 20214:23 pmRNSHolding(s) in Company
6th Dec 20215:20 pmRNSDirector/PDMR Shareholding
6th Dec 20215:20 pmRNSDirector/PDMR Shareholding
6th Dec 20215:20 pmRNSDirector/PDMR Shareholding
23rd Nov 20217:00 amRNSFY22 Interim Results
3rd Nov 20217:00 amRNSDirectorate Change & Trading Update
26th Oct 202112:48 pmRNSDirector/PDMR Shareholding
26th Oct 202112:47 pmRNSDirector/PDMR Shareholding
16th Sep 20213:10 pmRNSNED Appointment
18th Aug 20214:45 pmRNSDirector/PDMR Shareholding
2nd Aug 20217:00 amRNSDirector/PDMR Shareholding
29th Jul 20217:00 amRNSTrading Statement
21st Jul 20211:08 pmRNSHolding(s) in Company
16th Jul 20219:41 amRNSChange in Director’s details
8th Jul 20213:22 pmRNSResult of AGM
8th Jul 20219:45 amRNSDirector/PDMR Shareholding
16th Jun 20216:18 pmRNSHolding(s) in Company
15th Jun 20215:30 pmRNSHolding(s) in Company
9th Jun 20218:31 amRNSAnnual Report & Accounts and Notice of AGM
4th Jun 20219:38 amRNSDirector/PDMR Shareholding
3rd Jun 202112:22 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.